Report Detail
Global Prescription Dermatological Drugs Market Insights and Forecast to 2026
- RnM4166694 |
- 26 August, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Prescription Dermatological Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prescription Dermatological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Prescription Dermatological Drugs market is segmented into
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs
Segment by Application, the Prescription Dermatological Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Prescription Dermatological Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prescription Dermatological Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prescription Dermatological Drugs Market Share Analysis
Prescription Dermatological Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prescription Dermatological Drugs business, the date to enter into the Prescription Dermatological Drugs market, Prescription Dermatological Drugs product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Merck
Bayer
Mylan Pharmaceuticals
Pfizer
F. Hoffmann-La Roche
Allergan
Bausch Health
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation
1 Study Coverage
- 1.1 Prescription Dermatological Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Prescription Dermatological Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type
- 1.4.2 Anti-acne Drugs
- 1.4.3 Anti-aging Drugs
- 1.4.4 Dermatitis Drugs
- 1.4.5 Hair Loss Drugs
- 1.4.6 Psoriasis Drugs
- 1.4.7 Skin Cancer Drugs
- 1.4.8 Melasma Drugs
- 1.4.9 Seborrhea Drugs
- 1.5 Market by Application
- 1.5.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Prescription Dermatological Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Prescription Dermatological Drugs Revenue 2015-2026
- 2.1.2 Global Prescription Dermatological Drugs Sales 2015-2026
- 2.2 Global Prescription Dermatological Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Prescription Dermatological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Prescription Dermatological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prescription Dermatological Drugs Competitor Landscape by Players
- 3.1 Prescription Dermatological Drugs Sales by Manufacturers
- 3.1.1 Prescription Dermatological Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Prescription Dermatological Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Prescription Dermatological Drugs Revenue by Manufacturers
- 3.2.1 Prescription Dermatological Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Prescription Dermatological Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Prescription Dermatological Drugs Revenue in 2019
- 3.2.5 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Prescription Dermatological Drugs Price by Manufacturers
- 3.4 Prescription Dermatological Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Prescription Dermatological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Prescription Dermatological Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Prescription Dermatological Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Prescription Dermatological Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Prescription Dermatological Drugs Sales by Type (2015-2020)
- 4.1.2 Global Prescription Dermatological Drugs Revenue by Type (2015-2020)
- 4.1.3 Prescription Dermatological Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Prescription Dermatological Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Prescription Dermatological Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Prescription Dermatological Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Prescription Dermatological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Prescription Dermatological Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Prescription Dermatological Drugs Sales by Application (2015-2020)
- 5.1.2 Global Prescription Dermatological Drugs Revenue by Application (2015-2020)
- 5.1.3 Prescription Dermatological Drugs Price by Application (2015-2020)
- 5.2 Prescription Dermatological Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Prescription Dermatological Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Prescription Dermatological Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Prescription Dermatological Drugs by Country
- 6.1.1 North America Prescription Dermatological Drugs Sales by Country
- 6.1.2 North America Prescription Dermatological Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Prescription Dermatological Drugs Market Facts & Figures by Type
- 6.3 North America Prescription Dermatological Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Prescription Dermatological Drugs by Country
- 7.1.1 Europe Prescription Dermatological Drugs Sales by Country
- 7.1.2 Europe Prescription Dermatological Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Prescription Dermatological Drugs Market Facts & Figures by Type
- 7.3 Europe Prescription Dermatological Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Prescription Dermatological Drugs by Region
- 8.1.1 Asia Pacific Prescription Dermatological Drugs Sales by Region
- 8.1.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Prescription Dermatological Drugs by Country
- 9.1.1 Latin America Prescription Dermatological Drugs Sales by Country
- 9.1.2 Latin America Prescription Dermatological Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Prescription Dermatological Drugs Market Facts & Figures by Type
- 9.3 Central & South America Prescription Dermatological Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Prescription Dermatological Drugs by Country
- 10.1.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country
- 10.1.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Corporation Information
- 11.1.2 Johnson & Johnson Description and Business Overview
- 11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
- 11.1.5 Johnson & Johnson Related Developments
- 11.2 Merck
- 11.2.1 Merck Corporation Information
- 11.2.2 Merck Description and Business Overview
- 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck Prescription Dermatological Drugs Products Offered
- 11.2.5 Merck Related Developments
- 11.3 Bayer
- 11.3.1 Bayer Corporation Information
- 11.3.2 Bayer Description and Business Overview
- 11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bayer Prescription Dermatological Drugs Products Offered
- 11.3.5 Bayer Related Developments
- 11.4 Mylan Pharmaceuticals
- 11.4.1 Mylan Pharmaceuticals Corporation Information
- 11.4.2 Mylan Pharmaceuticals Description and Business Overview
- 11.4.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products Offered
- 11.4.5 Mylan Pharmaceuticals Related Developments
- 11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Description and Business Overview
- 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Prescription Dermatological Drugs Products Offered
- 11.5.5 Pfizer Related Developments
- 11.6 F. Hoffmann-La Roche
- 11.6.1 F. Hoffmann-La Roche Corporation Information
- 11.6.2 F. Hoffmann-La Roche Description and Business Overview
- 11.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 F. Hoffmann-La Roche Prescription Dermatological Drugs Products Offered
- 11.6.5 F. Hoffmann-La Roche Related Developments
- 11.7 Allergan
- 11.7.1 Allergan Corporation Information
- 11.7.2 Allergan Description and Business Overview
- 11.7.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Allergan Prescription Dermatological Drugs Products Offered
- 11.7.5 Allergan Related Developments
- 11.8 Bausch Health
- 11.8.1 Bausch Health Corporation Information
- 11.8.2 Bausch Health Description and Business Overview
- 11.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bausch Health Prescription Dermatological Drugs Products Offered
- 11.8.5 Bausch Health Related Developments
- 11.9 PharmaDerm Pharmaceuticals
- 11.9.1 PharmaDerm Pharmaceuticals Corporation Information
- 11.9.2 PharmaDerm Pharmaceuticals Description and Business Overview
- 11.9.3 PharmaDerm Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products Offered
- 11.9.5 PharmaDerm Pharmaceuticals Related Developments
- 11.10 Allergan Inamed Corporation
- 11.10.1 Allergan Inamed Corporation Corporation Information
- 11.10.2 Allergan Inamed Corporation Description and Business Overview
- 11.10.3 Allergan Inamed Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products Offered
- 11.10.5 Allergan Inamed Corporation Related Developments
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Corporation Information
- 11.1.2 Johnson & Johnson Description and Business Overview
- 11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
- 11.1.5 Johnson & Johnson Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Prescription Dermatological Drugs Market Estimates and Projections by Region
- 12.1.1 Global Prescription Dermatological Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Prescription Dermatological Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Prescription Dermatological Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Prescription Dermatological Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Prescription Dermatological Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Prescription Dermatological Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Prescription Dermatological Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Prescription Dermatological Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Prescription Dermatological Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Prescription Dermatological Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Prescription Dermatological Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Prescription Dermatological Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Prescription Dermatological Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Prescription Dermatological Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Prescription Dermatological Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Prescription Dermatological Drugs. Industry analysis & Market Report on Prescription Dermatological Drugs is a syndicated market report, published as Global Prescription Dermatological Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Prescription Dermatological Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
